N/A
N=90
Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate
Ejaculatory Dysfunction · BPH
Bottom Line
View on ClinicalTrials.gov: NCT05914519 ↗Enrolled (actual)
90
Serious AEs
1.1%
Results posted
Jan 2026
Primary outcome: Primary: Preservation of Ejaculation — 34; 8 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Ejaculatory Preserving Transurethral resection of prostate (Procedure); Standard Transurethral Resection of prostate (Procedure)
- Age
- Adult, Older Adult · 45+ yrs
- Sex
- Male
- Sponsor
- Sohag University
- Primary completion
- Jan 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Preservation of Ejaculation |
34; 8 | — |
| SECONDARY Maximum Flow Rate (Qmax) |
18.78; 19.71 | — |
Summary
The purpose of this study is to assess the outcomes and efficacy of ejaculatory preserving TURP in terms of voiding, erectile function, and ejaculation.
Eligibility Criteria
Inclusion Criteria
- Adult patient > 45 years old.
- Drug refractory urinary retention.
- Prostate volume range: 20-60 mL.
- IPSS > 19 after the medical therapy failure.
- Qmax < 10 mL/s.
- PSA < 4 ng/mL.
- Active and healthy sexual life.
Exclusion Criteria
- History of prostate or urethral surgery.
- Neurogenic bladder.
- UTI.
- Urethral stricture disease.
- prostate cancer.
- Bleeding diathesis.
- Capsular or bladder perforation during surgery.
Data sourced from ClinicalTrials.gov (NCT05914519). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.